And I think Southoz is clearly the resident expert in clinical trial stats, so if you don't mind I prefer his opinion over your good self and the other posters. He also set out his reasoning and I don't see any reason not to accept it.
CEO Itescu needs to go, page-147
-
- There are more pages in this discussion • 761 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
0.030(3.39%) |
Mkt cap ! $1.067B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $4.254M | 4.622M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 149636 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 25457 | 15 |
View Market Depth
| Last trade - 15.07pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |